Does Timing of Colon Procedures Affect Outcomes in D-IBS Trials? - Wikidata - awgldk - TriplyDB

Does Timing of Colon Procedures Affect Outcomes in D-IBS Trials?

Does Timing of Colon Procedures Affect Outcomes in D-IBS Trials?

http://www.wikidata.org/entity/Q53456521

about

Does Timing of Colon Procedures Affect Outcomes in D-IBS Trials?

http://www.wikidata.org/entity/Q53456521

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Does Timing of Colon Procedures Affect Outcomes in D-IBS Trials?

@en

type

label

Does Timing of Colon Procedures Affect Outcomes in D-IBS Trials?

@en

prefLabel

Does Timing of Colon Procedures Affect Outcomes in D-IBS Trials?

@en

P1433

Q53456521-3B466868-4730-410F-9870-ABD9E7A91F4A

P1476

Q53456521-F1E775CB-BDF4-4DFC-8FBF-4E4CB469752E

P2093

Q53456521-4C3D90C8-98E1-42F3-9E28-D497E92EC0A1

Q53456521-C3777BEA-140C-48F2-859B-787C72C08057

Q53456521-F70CA49E-A8C5-4570-98EE-DC3F58E73A09

Q53456521-FEC806A3-2D49-4D54-9AE5-509C05DBA0AF

P2860

Q53456521-2D36FDE9-312F-42E5-89B7-5F9A66CA7BF8

Q53456521-60DEAC61-7254-41B0-9056-61E251C11C01

Q53456521-92ECDFB6-3A63-4B4D-AD61-CD1FD326FE6A

Q53456521-972FF8BF-CB43-472A-A164-F6F1452E8596

Q53456521-A627D646-EE3E-462F-8AFE-6E6D2A4C3F6C

Q53456521-B4C9C116-CAD5-4CE1-8239-003AAA36FA70

Q53456521-E77A01C2-6EB9-4E70-B926-DB6B1AA2633C

P304

Q53456521-65CEE263-9200-48E0-8705-00C86807693F

P31

Q53456521-650EFB34-059C-40B9-8C52-603321E729EE

P356

Q53456521-EBA17A46-A51F-4581-AC43-F184B16592AA

P433

Q53456521-C54BFB03-FD12-4606-A421-FF21D34C97FC

P478

Q53456521-B43817E3-B6BB-4EF5-9490-E561E603E297

P577

Q53456521-EA8499ED-45C5-4BF0-8F77-367A6D576086

P698

Q53456521-A68F5D1B-71CD-4522-9547-588449BF8668

P932

Q53456521-48AF6A3C-3F37-473C-B4C7-5A21D584680E

P356

P1433

Gastroenterology research

P1476

Does Timing of Colon Procedures Affect Outcomes in D-IBS Trials?

@en

P2093

Allen W Mangel

http://www.w3.org/2001/XMLSchema#string

Beth Sherrill

http://www.w3.org/2001/XMLSchema#string

Jianmin Wang

http://www.w3.org/2001/XMLSchema#string

Lynne A Hamm

http://www.w3.org/2001/XMLSchema#string

P2860

Review article: the safety and efficacy of alosetron, a 5-HT3 receptor antagonist, in female irritable bowel syndrome patients.

A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation

Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome.

A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome.

Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist.

An office guide to whole-gut transit time. Patients' recollection of their stool form.

Balancing drug risk and benefit: toward refining the process of FDA decisions affecting patient care.

P304

185-190

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4021/GR238E

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27956995

http://www.w3.org/2001/XMLSchema#string

P932

5139714

http://www.w3.org/2001/XMLSchema#string